高脂配方液体喂养对COVID-19危重患者PCO2值及呼吸辅助设备使用时间的影响

Q4 Health Professions
Dewi Susanti Febri, Gestina Aliska, Afriani Afriani
{"title":"高脂配方液体喂养对COVID-19危重患者PCO2值及呼吸辅助设备使用时间的影响","authors":"Dewi Susanti Febri, Gestina Aliska, Afriani Afriani","doi":"10.52403/ijrr.20231035","DOIUrl":null,"url":null,"abstract":"Background: In December 2019, WHO announced the outbreak of COVID-19 disease caused by SARSCOV2. COVID-19 is a global pandemic characterized by high morbidity and mortality. SARS-CoV2 with there are many symptoms, about 20-26% of patients with COVID-19 pneumonia become severe or critical, requiring hospitalization for respiratory support. In Indonesia, COVID-19 has been increasing since 2020, and on February 2021, the Covid-19.go.id page had 1.157.837 confirmed cases, 176.291 active cases, 949.990 recovered, and 31.556 death cases. Acute respiratory complications requiring treatment in the intensive care unit are the main cause of high morbidity and mortality in patients with COVID-19. Nutrition therapy has influenced for outcomes of COVID-19 patients. Methods: The primary purpose of this study was to compare the value of PCO2, and duration of use of respiratory support for COVID-19 patients with critical illness. The result compared the COVID-19 patients who had been administered with high lipid formula nutrition (PULMOSOL) and patients who had been administered with standard liquid formula nutrition. The rate of the intervention group that experienced an increase in PCO2 was 55.6%, higher than those who experienced a decrease in PCO2 (50%). Results: Based on the analysis results, there was no difference in the administration of PULMOSOL and standard formula based on PCO2 in the use of ventilators in COVID-19 critically ill patients in Dr. M Djamil Padang General Hospital (p>0.05) with HR = 1.39 (95% CI 1.55-3.55). In patients with increased PCO2, it was found that the intervention group who died was 55.6%, lower compared to the control group (62.5%). The same in patients with decreased pCO2, group the intervention group who died was 50.0%, higher than the control group (40%). Conclusion: Statistical tests demonstrated there was no relationship between the administration of PULMOSOL and the outcome of critically ill COVID-19 (p>0.05). Keywords: Covid-19, critically ill, nutrition, high lipid formula","PeriodicalId":13809,"journal":{"name":"International Journal of Current Research and Review","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Effect of High Fat Formula Liquid Feeding on the Value of PCO2 and Duration of Use of Respiratory Aids for COVID-19 Patients with Critical Illness\",\"authors\":\"Dewi Susanti Febri, Gestina Aliska, Afriani Afriani\",\"doi\":\"10.52403/ijrr.20231035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: In December 2019, WHO announced the outbreak of COVID-19 disease caused by SARSCOV2. COVID-19 is a global pandemic characterized by high morbidity and mortality. SARS-CoV2 with there are many symptoms, about 20-26% of patients with COVID-19 pneumonia become severe or critical, requiring hospitalization for respiratory support. In Indonesia, COVID-19 has been increasing since 2020, and on February 2021, the Covid-19.go.id page had 1.157.837 confirmed cases, 176.291 active cases, 949.990 recovered, and 31.556 death cases. Acute respiratory complications requiring treatment in the intensive care unit are the main cause of high morbidity and mortality in patients with COVID-19. Nutrition therapy has influenced for outcomes of COVID-19 patients. Methods: The primary purpose of this study was to compare the value of PCO2, and duration of use of respiratory support for COVID-19 patients with critical illness. The result compared the COVID-19 patients who had been administered with high lipid formula nutrition (PULMOSOL) and patients who had been administered with standard liquid formula nutrition. The rate of the intervention group that experienced an increase in PCO2 was 55.6%, higher than those who experienced a decrease in PCO2 (50%). Results: Based on the analysis results, there was no difference in the administration of PULMOSOL and standard formula based on PCO2 in the use of ventilators in COVID-19 critically ill patients in Dr. M Djamil Padang General Hospital (p>0.05) with HR = 1.39 (95% CI 1.55-3.55). In patients with increased PCO2, it was found that the intervention group who died was 55.6%, lower compared to the control group (62.5%). The same in patients with decreased pCO2, group the intervention group who died was 50.0%, higher than the control group (40%). Conclusion: Statistical tests demonstrated there was no relationship between the administration of PULMOSOL and the outcome of critically ill COVID-19 (p>0.05). Keywords: Covid-19, critically ill, nutrition, high lipid formula\",\"PeriodicalId\":13809,\"journal\":{\"name\":\"International Journal of Current Research and Review\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Current Research and Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52403/ijrr.20231035\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Health Professions\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Current Research and Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52403/ijrr.20231035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0

摘要

背景:2019年12月,世卫组织宣布sars病毒引起的2019冠状病毒病暴发。COVID-19是一种全球大流行,其特点是发病率和死亡率高。SARS-CoV2伴有许多症状,约有20-26%的COVID-19肺炎患者变为重症或危重,需要住院接受呼吸支持。在印度尼西亚,自2020年以来,COVID-19一直在增加,2021年2月,COVID-19 .go也在增加。确诊病例1.157.837例,活跃病例176.291例,康复病例949.990例,死亡病例31.556例。需要在重症监护病房治疗的急性呼吸道并发症是导致COVID-19患者高发病率和高死亡率的主要原因。营养治疗对COVID-19患者的预后有影响。方法:本研究的主要目的是比较COVID-19危重患者的PCO2值和呼吸支持使用时间。结果比较了使用高脂配方营养(PULMOSOL)的COVID-19患者和使用标准液体配方营养的患者。干预组PCO2升高的比例为55.6%,高于PCO2降低的比例(50%)。结果:分析结果显示,M . Djamil Padang总医院新冠肺炎危重患者使用呼吸机时,使用PULMOSOL与基于PCO2的标准配方无差异(p>0.05), HR = 1.39 (95% CI 1.55 ~ 3.55)。在PCO2升高的患者中,干预组的死亡率为55.6%,低于对照组的62.5%。在pCO2降低的患者中,干预组的死亡率为50.0%,高于对照组(40%)。结论:经统计学检验,PULMOSOL给药与危重患者COVID-19转归无相关性(p < 0.05)。关键词:新冠肺炎危重症营养高脂配方
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Effect of High Fat Formula Liquid Feeding on the Value of PCO2 and Duration of Use of Respiratory Aids for COVID-19 Patients with Critical Illness
Background: In December 2019, WHO announced the outbreak of COVID-19 disease caused by SARSCOV2. COVID-19 is a global pandemic characterized by high morbidity and mortality. SARS-CoV2 with there are many symptoms, about 20-26% of patients with COVID-19 pneumonia become severe or critical, requiring hospitalization for respiratory support. In Indonesia, COVID-19 has been increasing since 2020, and on February 2021, the Covid-19.go.id page had 1.157.837 confirmed cases, 176.291 active cases, 949.990 recovered, and 31.556 death cases. Acute respiratory complications requiring treatment in the intensive care unit are the main cause of high morbidity and mortality in patients with COVID-19. Nutrition therapy has influenced for outcomes of COVID-19 patients. Methods: The primary purpose of this study was to compare the value of PCO2, and duration of use of respiratory support for COVID-19 patients with critical illness. The result compared the COVID-19 patients who had been administered with high lipid formula nutrition (PULMOSOL) and patients who had been administered with standard liquid formula nutrition. The rate of the intervention group that experienced an increase in PCO2 was 55.6%, higher than those who experienced a decrease in PCO2 (50%). Results: Based on the analysis results, there was no difference in the administration of PULMOSOL and standard formula based on PCO2 in the use of ventilators in COVID-19 critically ill patients in Dr. M Djamil Padang General Hospital (p>0.05) with HR = 1.39 (95% CI 1.55-3.55). In patients with increased PCO2, it was found that the intervention group who died was 55.6%, lower compared to the control group (62.5%). The same in patients with decreased pCO2, group the intervention group who died was 50.0%, higher than the control group (40%). Conclusion: Statistical tests demonstrated there was no relationship between the administration of PULMOSOL and the outcome of critically ill COVID-19 (p>0.05). Keywords: Covid-19, critically ill, nutrition, high lipid formula
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Current Research and Review
International Journal of Current Research and Review Health Professions-Health Professions (miscellaneous)
自引率
0.00%
发文量
162
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信